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Abstract
Introduction: Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS), both
are related to higher prevalence of mycoses, especially oral candidosis, but also superficial mycoses. Fungal infections
of the skin and its appendages are the most frequent dermatological complications in HIV patients and clinical man-
ifestations of those infections are often atypical and more severe than in immunocompetent individuals.
Aim: The purpose of the study was evaluation of the presence of dermatophytes in foot interdigital spaces in HIV
patients in relation with various factors concerning the patient.
Material and methods: The population under study were patients at the Infectious Diseases Clinic. The research
comprised filling in questionnaires, physical examinations, evaluation of immunological status, and mycological
examination of swabs from interdigital spaces.
Results: Out of the 120 HIV infected patients under study, foot skin lesions were observed in 40 cases (33.3%) while
dermatophytes were isolated from 12 patients (10%). Trichophyton mentagrophytes was isolated from 7 patients
(5.8%), and Trichophyton rubrum from 6 (5.0%); both of the species were isolated from 1 patient. The prevalence of
dermatophytes did not depend on the patient’s sex, sexual orientation, CD4 cells count, HCV co-infection, anti-
retroviral therapy nor clinical manifestations on the feet.
Conclusions: The prevalence of dermatophytes in foot interdigital spaces in HIV patients amounted to 10% (simi-
larly as in imunocompetent individuals) and did not depend significantly on any of the factors tested. It appears
that contact with the fungi is the main factor responsible for infection.
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Introduction
Superficial mycoses are an essential epidemiological
problem because they are widespread and are easily
transferred from one person to another. Despite constant
progress in diagnosis and management, they still remain
a serious therapeutical problem. Recently a constant
increase in the prevalence of both invasive and superfi-
cial mycoses has been observed, which is related to
a growing population specifically susceptible to such infec-
tions.
Human immunodeficiency virus (HIV) infection is
accompanied by increasing immunodeficiency, which
increases the risk of various infectious diseases, includ-
ing mycoses [1]. In HIV-positive and acquired immune
deficiency syndrome (AIDS) patients, the main problem
is infection of mucous membranes with Candida; it par-
ticularly concerns the oral cavity, throat, larynx and vagi-
na. Candidosis is the most frequent mycosis in this group
of patients and is known as an “AIDS-defining illness”.
When the number of CD4 lymphocytes is very low, oth-
er invasive fungal infections may occur (systemic, dis-
seminated) caused both by yeasts (invasive candidosis,
cryptococcal meningoencephalitis) and by filamentous
fungi (invasive aspergillosis) [2-6]. Superficial mycoses
occur in HIV patients less frequently than mycoses of
mucous membranes, nevertheless, they are the most fre-
quent complications in those persons [7]. Skin infections
in HIV patients may be either primary superficial infec-
tions that may disseminate to other tissues and organs or
be a superficial manifestation of an invasive infection [4].
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The clinical manifestations of superficial mycoses in HIV
patients are more severe, the lesions may be atypical and
resistant to conventional treatment [4, 7-9]. Such infec-
tions in HIV patients may be severe and even life threat-
ening because skin maceration in the interdigital spaces
may create the entry of infection with highly pathogen-
ic fungi and/or bacteria [10]. Moreover, superficial
mycoses, similarly to other diseases of the skin and its
appendages, may considerably influence functioning of
the patient in various situations, increase his or her psy-
chosocial discomfort and thus deteriorate the quality of
life. Those diseases may cause a feeling of shame
because of unsightly appearance, anxiety about spread-
ing of the disease to other parts of the body, as well as
anger and depression. Superficial mycoses may interfere
with social activity of the patient: his or her profession-
al activity, social contacts, rest and sexual activity. The
latter is significantly limited by the underlying disease in
HIV patients [10-12].
Aim
The objective of the study was evaluation of the occur-
rence of dermatophytes in foot interdigital spaces in HIV
patients as well as analysis of the influence of CD4 cell
level and other patient characteristics (sex, sexual orien-
tation, other diseases, antiretroviral drugs) on the preva-
lence of dermatophytes.
Material and methods
The population under study comprised HIV patients
treated at the Clinic of Infectious Diseases, Chair of Gas-
troenterology, Hepatology and Infectious Diseases, Jagiel-
lonian University Medical College in Kraków, aged over 
18 years who agreed in writing to participate in the study.
An agreement of the Bioethical Committee of the
Jagiellonian University was obtained (KBET/24/B/2009,
KBET/56/B/2010). The financial support was obtained
from the Jagiellonian University Medical College research
grant K/ZBW/000569.
The patients had to fill in an anonymous question-
naire concerning their age, residence (urban/rural), edu-
cation, job, sexual orientation, route and time of HIV infec-
tion, concomitant diseases and actual medication.
Additionally, the medical history was taken and physical
examination of the foot skin was performed.
At physical examination, smears from the left and
right foot interdigital spaces were taken with a spatula
with cotton wool rinsed with sterile saline. The clinical
materials were cultured on two microbiological media:
Sabouraud medium with chloramphenicol, and Sabouraud
medium with chloramphenicol and cycloheximide. The
cultures were incubated at 27°C for 4 weeks. The fungi
grown in the cultures were identified phenotypically on
the basis of colony morphology, micromorphology in
preparations from the culture and slide microculture as
well as using biochemical tests.
The data were processed statistically using the lan-
guage and environment R, version 2.9.1 (2009). The results
were considered as significant when p ≤ 0.05.
Results
A total of 120 HIV patients were included into the
study: 91 males aged 20-73 years (mean age 37.7 ±9.8
years), and 29 females aged 24-44 years (mean age 34.6
±4.8 years). The mean age in the entire group was 37.0
±8.9 years.
Out of the males, 51 (56.0%) declared that they are het-
erosexuals, 30 (33.0%) – homosexuals, and 10 (11.0%)
bisexuals. In the group of females, 26 (89.7%) declared
their heterosexuality and 1 (3.4%) – homosexuality. One
woman refused to answer this question. 
At the clinical materials to mycological examinations
sampling moment, the number of CD4 varied from 2/μl to
1065/μl. Patients with CD4 count between 200/μl and
499/μl dominated. 
The most frequent disease in the group was hepati-
tis C virus infection (HCV). It was detected in 35 (29.2%)
patients: in 26 males (28.6%) and in 16 females (55.2%).
During sampling smears from the interdigital spaces, 
85 patients (70.8%) were under antiretroviral treatment:
63 males (69.2%) and 22 (75.9%) females. 
On physical examination, skin lesions of the feet were
observed in 40 patients (33.3%): flare, scaling, discoloration,
dermatorrhexis, pachyderma, discharge. Six patients (5.0%)
complained about itching, pain, burning and sweating. 
Dermatophytes were isolated from 12 patients (10.0%):
11 males (12.1%) and 1 female (3.4%). Two dermatophyte
species were detected in the clinical materials: Trichophy-
ton rubrum and T. mentagrophytes. Trichophyton rubrum
was found in 6 patients (5.0%), and T. mentagrophytes in
7 (5.8%), while in 1 patient, colonization with both of the
species was found. 
Dermatophytes were isolated from 6 (15.0%) out of the
40 patients with foot skin lesions. Dermatophytes were
also isolated from 6 (7.5%) of the remaining 80 patients
(66.6%) with no foot skin lesions. The prevalence of der-
matophytes did not depend on the presence or lack of skin
lesions (Table 1). 
Dermatophytes were isolated only in one of the 6 pa -
tients complaining about symptoms from their feet, 
while they were present in 11 (9.6%) of the 114 symptom-
less patients. No relationship was found between the pres-
ence of symptoms and the prevalence of dermatophyte
isolations (Table 1).
It was also found that the number of CD4 does not
influence the occurrence of dermatophytes. Moreover, no
significant relationship was found between the prevalence
of dermatophytes vs. HCV co-infection and/or antiretrovi-
ral treatment (Table 1).
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Discussion
Both HIV infection and AIDS are related to higher
prevalence of mycoses [1]. Candidosis of mucosa is usu-
ally diagnosed in HIV patients, however, mycoses of the
skin and its appendages are also frequent [4, 13]. Mycoses
of the skin and its appendages are the most frequent com-
plications in HIV patients; clinical manifestations of those
infections are often atypical and more severe than in
immunocompetent individuals [4, 6, 8, 9].
Foot mycosis is the most frequent skin mycosis in the
general population and accounts for 30% of all of the fun-
gal skin infections [14]. The international epidemiological
study (Achilles project) revealed that as many as 42% of
the Polish population suffers from foot mycosis [15]. The
most frequent causative agents of those infections, sim-
ilarly to other superficial mycoses, are undoubtedly der-
matophytes. Macura et al. [16] analyzed the prevalence
of dermatophytes in clinical materials sampled from out-
patients suspected of superficial mycosis in Krakow in
the years 1998-2007. They detected presence of those
fungi in 38.6% of the toenail specimens and in 22.8% of
foot skin scrapings. Dermatophyte infections are also com-
mon in HIV patients, however, there is no evidence that
they are more frequent in HIV-positive than in HIV-nega-
tive patients [13].
In HIV patients, tinea pedis is thought to be the most
frequent skin mycosis, together with tinea corporis, tinea
cruris and onychomycosis [13]. In the present study, we
have detected the presence of dermatophytes in foot
interdigital spaces in 10.0% of HIV patients. The finding
is comparable to the prevalence of dermatophytes in
a group of soldiers (unpublished data), who are also pre-
disposed to development of superficial mycoses. Similar
findings were obtained by di Silverio’s et al. [17] who eval-
uated the occurrence of dermatophytes in selected sites
on the HIV patients’ skin: in sportsmen vs. control group.
The prevalence of their dermatophyte isolations from
interdigital spaces was similar to ours: 12.5%. They did
not detect the difference of the prevalence of dermato-
phytes in HIV+ patients vs. sportsmen (20% vs. 28.1%),
however, dermatophytes were most often isolated in the
HIV patients’ group than in the control group (20% vs. 6%)
[17]. Lohoué Petmy et al. [18] diagnosed tinea pedis in HIV
patients in somewhat lower percentage than it was found
by us or di Silverio et al. [17]. Foot mycosis was diagnosed
in 7.4% of the patients; it was one of the most frequent
mycosis in those patients, just after oral candidosis, tinea
corporis (8.8%) and tinea versicolor (8.1%) [18]. A consid-
erably lower prevalence of foot mycosis in HIV patients
was found by Kaviarasan et al. [19]. In their study on 185
HIV patients, the most frequent skin mycosis was tinea
corporis (11.9%), next to it tinea cruris (9.7%). Tinea pedis
was detected only in 3.8% of the patients. The above find-
ings are controversial to those obtained by Rodwell et al.
[1] and Korting et al. [20]. Rodwell et al. detected tinea
pedis in 52 out of 105 HIV patients (49.5%) while Korting
et al. detected presence of dermatophytes in foot skin
scrapings in 42% of 105 HIV patients.
In our investigations, only two dermatophyte species
were isolated: T. rubrum and T. mentagrophytes, and their
Table 1. The occurrence of dermatophytes in foot interdigital spaces in HIV patients in relation to various factors
Factors Number of patients Number and percentage of patients Fischer test
in whom dermatophytes were isolated
Sex Male 91 11 (12.1%) p = 0.2894
Female 29 1 (3.4%)
Sexual orientation Heterosexual 77 5 (6.5%) p = 0.1104
Homosexual 31 5 (16.1%)
Bisexual 11 2 (18.2%)
Foot skin lesions Present 40 6 (15.0%) p = 0.2113
None 80 6 (7.5%)
Symptoms Present 6 1 (16.7%) p = 0.4761
None 114 11 (9.6%)
CD4 cell count ≤ 199/μl 35 5 (14.3%) p = 0.4452
200-499/μl 60 6 (10.0%)
≥ 500/μl 25 1 (4.0%)
HCV co-infection 35 2 (5.7%) p = 0.5078
Antiretroviral therapy 85 8 (9.4%) p = 0.7286
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prevalence was comparable. We have established in our
investigations, carried out since the 1970s that just those
two species constantly dominate in our region and that
T. rubrum considerably outnumbers T. mentagrophytes
[16, 21]. The preponderance of T. rubrum in HIV patients
was also reported by other researchers’ teams, among
others, Rodwell et al. [1] and Korting et al. [20].
The CD4 cell count in HIV patients is an index of their
immunological status. The influence of CD4 cell count on
the occurrence of mycoses: on mucosa, superficial and
deep-seated was tested many times. Even though the
influence of those lymphocytes on infections with yeasts
Candida is not controversial [4], in the case of dermato-
mycoses, the available data appear to be contradictory.
Gregory [22] claims that decrease of CD4 count causes
occurrence of various skin lesions, e.g. onychomycosis
develops at CD4 count around 450/μl. Similarly, Aly and
Berger [13] and Gupta et al. [10] established that ony-
chomycosis occurs at the early stage of HIV infection, at
CD4 count around 400/μl. In our study, similarly as in that
by Rodwell et al. [1] no relationship was found between
the presence of dermatophytes in foot interdigital spaces
and CD4 count (Fisher test, p = 0.4452), however, der-
matophytes more often were present in patients with 
CD4 < 500/μl.
Previous investigations gave evidence of relationship
between sexual orientation and the presence of der-
matophytes [1, 23]. Torssander et al. [23] noted that der-
matomycoses occur more often in homosexuals. Rodwel
et al. [1] also found a higher prevalence of dermatophyte
in patients who reported homosexual contacts. In our
findings, the prevalence of dermatophytes in homo- and
bisexuals was 16.1% and 18.2%, respectively. In hetero-
sexuals the prevalence was lower: 6.5%, however, the dif-
ference was not significant (Fisher test, p = 0.1104).
Conclusions
Our study on the prevalence of dermatophytes in the
foot interdigital spaces in HIV patients did not reveal the
relationship between the immunological status of the
patient, his or her sexual orientation, and antiretroviral
treatment. The prevalence of dermatophyte isolations in
the group under study was 10.0%. It was comparable with
that in a group of soldiers (unpublished data) and was
twice lower than in patients referred to our institution by
dermatologists because of clinical manifestations of foot
mycosis. It may be concluded that HIV infection is not an
important factor conducive to foot dermatophytosis. The
main factor, similarly as in individuals with normal immu-
nity, may be contact with the pathogen.
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